Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

Sofie Lock Johansson, Helle Wulf-Johansson, Anders Schlosser, Ingrid L. Titlestad, Bruce Miller, Ruth Tal-Singer, Uffe Holmskov, Jørgen Vestbo, Grith Lykke Sørensen*

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

88 Downloads (Pure)

Abstrakt

Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.

OriginalsprogEngelsk
Artikelnummer00021-2019
TidsskriftERJ Open Research
Vol/bind5
Udgave nummer2
Antal sider4
ISSN2312-0541
DOI
StatusUdgivet - 1. apr. 2019

Fingeraftryk

Dyk ned i forskningsemnerne om 'Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients'. Sammen danner de et unikt fingeraftryk.

Citationsformater